{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:51:27Z","timestamp":1772142687068,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171819"],"award-info":[{"award-number":["81171819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272107"],"award-info":[{"award-number":["81272107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejphar.2016.09.034","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T10:31:47Z","timestamp":1475231507000},"page":"647-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Inhibitory effect of recombinant human endostatin on the proliferation of hypertrophic scar fibroblasts in a rabbit ear model"],"prefix":"10.1016","volume":"791","author":[{"given":"Yong-Fang","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Fei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.09.034_bib1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","author":"Baldin","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2016.09.034_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.09.034_bib3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjd.14263","article-title":"Flightless I is a key regulator of the fibroproliferative process in hypertrophic scarring and a target for a novel anti-scarring therapy","volume":"174","author":"Cameron","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2016.09.034_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.breast.2007.05.007","article-title":"Relationship between p53 and p27 expression following HER2 signaling","volume":"16","author":"Casalini","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.ejphar.2016.09.034_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1349-7006.2007.00459.x","article-title":"Signal transduction mediated by endostatin directly modulates cellular function of lung cancer cells in vitro","volume":"98","author":"Cui","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2016.09.034_bib6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/104303403766682250","article-title":"Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells","volume":"14","author":"Dkhissi","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2016.09.034_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.281.5381.1317","article-title":"A matter of life and cell death","volume":"281","author":"Evan","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2016.09.034_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2016.09.034_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20121627","article-title":"The cell cycle and pluripotency","volume":"451","author":"Hindley","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2016.09.034_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/TCRM.S82961","article-title":"Paclitaxel reduces formation of hypertrophic scars in the rabbit ear model","volume":"11","author":"Huang","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejphar.2016.09.034_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ar.20722","article-title":"Mechanism of fibroblast-like synoviocyte apoptosis induced by recombinant human endostatin in rats with adjuvant arthritis","volume":"291","author":"Huang","year":"2008","journal-title":"Anat. Rec."},{"key":"10.1016\/j.ejphar.2016.09.034_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2013.10.068","article-title":"Anti-proliferative effect of recombinant human endostatin on synovial fibroblasts in rats with adjuvant arthritis","volume":"723","author":"Huang","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.ejphar.2016.09.034_bib13","first-page":"3447","article-title":"Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression","volume":"8","author":"Jiang","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2016.09.034_bib14","doi-asserted-by":"crossref","first-page":"e47161","DOI":"10.1371\/journal.pone.0047161","article-title":"Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116","volume":"7","author":"Jin","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2016.09.034_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jamcollsurg.2007.03.001","article-title":"Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring","volume":"205","author":"Kryger","year":"2007","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ejphar.2016.09.034_bib16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/jid.2012.486","article-title":"Xiamenmycin attenuates hypertrophic scars by suppressing local inflammation and the effects of mechanical stress","volume":"133","author":"Liu","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.ejphar.2016.09.034_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tibs.2005.09.005","article-title":"Mammalian cyclin-dependent kinases","volume":"30","author":"Malumbres","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2016.09.034_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0945-053X(01)00151-2","article-title":"The role of collagen-derived proteolytic fragments in angiogenesis","volume":"20","author":"Marneros","year":"2001","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejphar.2016.09.034_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer","volume":"432","author":"Massague","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.09.034_bib20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2741\/2834","article-title":"Cell cycle control as a basis for cancer chemoprevention through dietary agents","volume":"13","author":"Meeran","year":"2008","journal-title":"Front. Biosci.: J. Virtual Libr."},{"key":"10.1016\/j.ejphar.2016.09.034_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.cellbio.13.1.261","article-title":"Cyclin-dependent kinases: engines, clocks, and microprocessors","volume":"13","author":"Morgan","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2016.09.034_bib22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00006534-199709000-00021","article-title":"Acute and chronic animal models for excessive dermal scarring: quantitative studies","volume":"100","author":"Morris","year":"1997","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.ejphar.2016.09.034_bib23","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1073\/pnas.91.17.8022","article-title":"Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle","volume":"91","author":"Musgrove","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2016.09.034_bib24","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-04-2427","article-title":"Endogenous inhibitors of angiogenesis","volume":"65","author":"Nyberg","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2016.09.034_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2016.09.034_bib26","first-page":"89","article-title":"Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression)","volume":"10","author":"Ozkara","year":"2004"},{"key":"10.1016\/j.ejphar.2016.09.034_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1126\/science.2683075","article-title":"G1 events and regulation of cell proliferation","volume":"246","author":"Pardee","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2016.09.034_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","article-title":"Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals","volume":"78","author":"Polyak","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2016.09.034_bib29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1101\/gad.7.8.1559","article-title":"Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts","volume":"7","author":"Quelle","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2016.09.034_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1631\/jzus.B1200077","article-title":"Endostatin inhibits hypertrophic scarring in a rabbit ear model","volume":"14","author":"Ren","year":"2013","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.ejphar.2016.09.034_bib31","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2174\/138161212799859639","article-title":"The architectural organization of human stem cell cycle regulatory machinery","volume":"18","author":"Stein","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.09.034_bib32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/aob\/mcq243","article-title":"Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation","volume":"107","author":"Strzalka","year":"2011","journal-title":"Ann. Bot."},{"key":"10.1016\/j.ejphar.2016.09.034_bib33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/labinvest.2008.101","article-title":"Deep dermal fibroblasts contribute to hypertrophic scarring","volume":"88","author":"Wang","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ejphar.2016.09.034_bib34","first-page":"1289","article-title":"Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells","volume":"23","author":"Wilson","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2016.09.034_bib35","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1096\/fj.10-178087","article-title":"Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation","volume":"25","author":"Wong","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2016.09.034_bib36","doi-asserted-by":"crossref","first-page":"e107463","DOI":"10.1371\/journal.pone.0107463","article-title":"Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt\/\u03b2-catenin signaling pathway","volume":"9","author":"Xu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2016.09.034_bib37","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/abbs\/gmt070","article-title":"Antitumor effects of Endostar on non-Hodgkin\u2019s lymphoma by regulating endothelial progenitor cells through protein kinase B-dependent pathway","volume":"45","author":"Yu","year":"2013","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"key":"10.1016\/j.ejphar.2016.09.034_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bjd.14108","article-title":"Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-beta\/Smad2\/3 signalling pathway","volume":"174","author":"Zhang","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejphar.2016.09.034_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1534734612463698","article-title":"Endostar injection inhibits rabbit ear hypertrophic scar formation","volume":"11","author":"ZhiYong","year":"2012","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"10.1016\/j.ejphar.2016.09.034_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12079-013-0195-5","article-title":"The molecular mechanism of hypertrophic scar","volume":"7","author":"Zhu","year":"2013","journal-title":"J. Cell Commun. Signal"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916306215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916306215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T03:42:18Z","timestamp":1572579738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916306215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S0014299916306215"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.09.034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effect of recombinant human endostatin on the proliferation of hypertrophic scar fibroblasts in a rabbit ear model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}